4.7 Article

Tolerability and comparative effectiveness of TNF, IL-17 and IL-23(p19) inhibitors in psoriatic arthritis: a target trial emulation study

Related references

Note: Only part of the references are listed.
Article Rheumatology

Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries

Alexander Egeberg et al.

Summary: This study examined the real-life drug survival of biologics and novel small-molecule therapies for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis. Results showed varying treatment responses to drugs with different mechanisms of action across the diseases, emphasizing the need for individualized treatment approaches.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2022)

Review Rheumatology

Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis

Philip J. Mease et al.

Summary: In a network meta-analysis comparing guselkumab with other targeted therapies for PsA, guselkumab demonstrated efficacy comparable to IL-17A and subcutaneous TNF inhibitors for arthritis relief, while offering better skin symptom improvement compared with many other treatments.

RHEUMATOLOGY (2021)

Review Medicine, Research & Experimental

An Update for the Clinician on Biologics for the Treatment of Psoriatic Arthritis

Maria Sole Chimenti et al.

BIOLOGICS-TARGETS & THERAPY (2020)

Review Immunology

Quality of life in psoriatic arthritis

Tania Gudu et al.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2018)

Review Medicine, General & Internal

Psoriatic arthritis 1 The pathogenesis of psoriatic arthritis

Douglas J. Veale et al.

LANCET (2018)

Article Rheumatology

International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trials

Ana-Maria Orbai et al.

ANNALS OF THE RHEUMATIC DISEASES (2017)

Article Rheumatology

Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score

Monika M. Schoels et al.

ANNALS OF THE RHEUMATIC DISEASES (2016)

Review Rheumatology

Advances in the management of psoriatic arthritis

Ignazio Olivieri et al.

NATURE REVIEWS RHEUMATOLOGY (2014)